|
Market Closed -
Nasdaq
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 4.090 USD | +0.74% |
|
+0.25% | +154.04% |
| 08-17 | B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating | MT |
| 08-13 | MacroGenics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: MacroGenics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 983.2 | 412.5 | 596.7 | 204 | 101.8 | 260.5 | - | - |
| Change | - | -58.04% | 44.66% | -65.82% | -50.07% | 155.81% | - | - |
| Enterprise Value (EV) | 983.2 | 412.5 | 366.9 | 204 | 101.8 | 260.5 | 260.5 | 260.5 |
| Change | - | -58.04% | -11.05% | -44.41% | -50.07% | 155.81% | 0% | 0% |
| P/E | -4.76x | -3.44x | -64.1x | -3.04x | -1.36x | -2.64x | -2.67x | -1.82x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.1x | 0.7x | -0x | -0.1x | -0.1x | 2.17x | -0x |
| Capitalization / Revenue | 12.7x | 2.71x | 10.2x | 1.36x | 0.68x | 2.27x | 2.65x | 2.74x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.27x | 2.65x | 2.74x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.82x | -1.99x | -1.55x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -3.1x | -1.87x | -1.99x |
| FCF Yield | -15.3% | -22% | -13.4% | -35.3% | -81.5% | -32.2% | -53.4% | -50.2% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.37 | -1.95 | -0.15 | -1.07 | -1.18 | -1.551 | -1.532 | -2.253 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 77.45 | 151.9 | 58.75 | 150 | 149.5 | 114.6 | 98.35 | 95 |
| EBITDA | -191.5 | -109.6 | -158.6 | - | - | - | - | - |
| EBIT 1 | -202.8 | -121.4 | -168.2 | -110.6 | -72.84 | -92.47 | -130.9 | -167.6 |
| Net income 1 | -202.1 | -119.8 | -9.058 | -66.97 | -74.62 | -88.02 | -127.6 | -200.7 |
| Net Debt | - | - | -229.8 | - | - | - | - | - |
| Reference price 2 | 16.050 | 6.710 | 9.620 | 3.250 | 1.610 | 4.090 | 4.090 | 4.090 |
| Nbr of stocks (in thousands) | 61,258 | 61,475 | 62,029 | 62,763 | 63,259 | 63,700 | - | - |
| Announcement Date | 2/24/22 | 3/15/23 | 3/7/24 | 3/20/25 | 3/9/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.95x | - | - | - | 259M | |
| 21.98x | 7.69x | 15.68x | 1.34% | 73.25B | |
| 35.55x | 9.09x | 27.97x | 0.04% | 61.95B | |
| -81.11x | 15.16x | -77.38x | -.--% | 28.02B | |
| 30.63x | 6x | 15.89x | -.--% | 24.15B | |
| -14.36x | 4.96x | -6.48x | -.--% | 23.01B | |
| 53.29x | 19.73x | 39.94x | 0.07% | 18.35B | |
| 26.57x | 5.01x | 16.8x | -.--% | 19.46B | |
| -664.91x | 38.2x | -17593.58x | -.--% | 15.92B | |
| 16.23x | 4.79x | 11.18x | -.--% | 12.96B | |
| Average | -57.91x | 12.29x | -1,950.00x | 0.16% | 27.73B | |
| Weighted average by Cap. | -24.99x | 10.61x | -1,003.04x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MGNX Stock
- Valuation MacroGenics, Inc.
Select your edition
All financial news and data tailored to specific country editions
